News

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Press Releases
BIO Welcomes Collaboration With New HHS, USTR…
The Biotechnology Innovation Organization (BIO) welcomes the confirmations this week of Katherine Tai to the position of U.S. Trade Representative (USTR) and Xavier Becerra to lead the Department of Health and Human Services (HHS).  The United…
New Mexico's Clean Fuel Standard Will Ignite…
Albuquerque, NM (March 11, 2021) — Today, the Biotechnology Innovation Organization (BIO) released the following statement applauding the passage of a clean fuel standard in New Mexico: “The passage of a clean fuel standard in New Mexico…
BIO responds to Congress' Covid-19 relief package
Today, Congress passed the “American Rescue Plan” – a $1.9 trillion coronavirus relief package aimed at alleviating some of the economic and health impacts of the COVID-19 pandemic. Upon passage of the bill, Dr. Michelle McMurry-Heath, president…
Letters, Testimony, & Comments
BIO Joins Coalition Letter to Biden…
Dear Secretary Buttigieg, National Climate Advisor McCarthy, and Director Deese: The undersigned organizations, representing aviation industry stakeholders including passenger and cargo carriers, business and general aviation, aircraft and engine…
BIO Comments on FDA’s Draft Guidance on Human…
On Tuesday, April 6th, BIO submitted comments on the U.S. Food and Drug Administration (FDA)’s January 2021 draft industry guidance on “Human Gene Therapy for Neurodegenerative Diseases.” In its comments, BIO stated that while the guidance covers…
BIO Comments on FDA’s Public Meeting Announcement…
On Friday, March 26th, BIO submitted comments on the U.S. Food and Drug Administration (FDA)’s public meeting announcement titled, “Best Practices for Development and Application of Disease Progression Models.” BIO appreciates that FDA is seeking…
Amicus Briefs
BIO Files Amicus Brief in Support of Rehearing…
BIO files amicus brief in support of a petition for rehearing related to patent-eligibility of diagnostic technology. 
BIO Files Amicus Brief on Case Addressing the…
BIO files an Amicus Brief on rehearing by the Precedential Opinion Panel of the Patent Trial and Appeal Board.
BIO Files Amicus Brief on Case Addressing…
BIO and PhRMA have submitted a brief in the U.S Court of Appeals for the Federal Circuit on behalf of appellant in Virnetx Inc. v. The Mangrove Partners. 
Blog Posts
Global Marketplace
April 15, 2021
Much has changed in the past year. Switzerland, however, remains a global leader in biotech innovation. New companies are leading the way. Deep Breath Intelligence, a spin-off from some of the top Swiss universities,…
Woman doctor
April 13, 2021
On March 16, 2021, a lone white gunman went on a shooting spree in three spas in the Atlanta area and killed eight people—six of whom were Asian women. This vicious crime is another indicator of rising anti-Asian…
Vaccine
April 12, 2021
The “I AM BIO” podcast returns with an important topic – how to address COVID-19 vaccine hesitancy. Full episode here: https://www.bio.org/podcast or on your favorite podcast platform including …